Vascular endothelial growth factor165-regulated nasopharyngeal carcinoma cell lines invasion and migration involve expression and activation of matrix metalloproteinase-2

Abstract

The effect of vascular endothelial growth factor (VEGF) overexpression on matrix metalloproteinase-2 (MMP-2) in nasopharyngeal carcinoma (NPC) cells in vitro and the possible mechanism involved were investigated, and the correlation between the expression of VEGF and MMP-2 in NPC evaluated. The NPC cells were transfected with PAd-trackVEGF165 plasmid. The expression levels of VEGF and MMP-2 mRNA and protein in NPC cells were detected by semi-quantitative RT-PCR and Western blot respectively. It was found that the expression of VEGF and MMP-2 mRNA and protein was significantly increased in NPC cells after transfection of VEGF165. It was concluded that the expression of VEGF was correlated to the in vitro invasion of NPC cells, and the induction of MMP-2 by VEGF was a key process of NPC cell invasion.

Keywords

nasopharyngeal carcinoma cells / vascular endothelial growth factor / matrix metalloproteinase-2 / gene transfection

References

[1] ZhangA., MengL., WangQ., et al.. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Oncol Rep, 2006, 15(4): 831-836

[2] KleinerD. E., Stetler-StevensonW. G.. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 1999, 43(Suppl): S422-S451

[3] International Agency for Research on Cancer, World Health Organization.. Epstein-Barr virus: summary of data reported and evaluation. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 70, 1997, Lyon, IARC Press: 255-262

[4] JiaW. H., HuangQ. H., LiaoJ., et al.. Trends in incidence and mortality of nasopharyngeal carcinoma over a 20–25 year period (1978/1983–2002) in Sihui and Cangwu counties in southern China. BMC Cancer, 2006, 6: 178-185

[5] AgulnikM., SiuL. L.. State-of-the-art management of nasopharyngeal carcinoma: current and future directions. Br J Cancer, 2005, 92: 799-806

[6] BrennanB.. Nasopharyngeal carcinoma. Orphanet J Rare Dis, 2006, 1: 23-27

[7] SteegP. S.. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med, 2006, 12: 895-904

[8] FerraraN.. VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer, 2002, 2: 795-803

[9] Abu-JawdehG. M., FaixJ. D., NiloffJ., et al.. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest, 1996, 74(6): 1105-1115

[10] O-charoenratP., Rhys-EvansP. H., ArcherD. J., et al.. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. Oral Oncol, 2002, 38: 73-80

[11] KawataR., ShimadaT., MaruyamaS., et al.. Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis. Acta Otolaryngol, 2002, 122: 101-106

[12] KuraharaS., ShinoharaM., IkebeT., et al.. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis. Head Neck, 1999, 21: 627-638

[13] KurizakiT., ToiM., TominagaT.. Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma. Oncol Rep, 1998, 5(3): 673-677